Form D · Other Health Care
Coagulex, Inc.
Houston, TX · CIK 0001730850
Offering snapshot reported Feb 13, 2018 · SEC filing
- Reported sold
- $263K Offering amount: $500K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 1, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2018 | Initial | $262,500 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305490
Source: Form D, filed Feb 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brijesh Gill | Director |
| Elvin Jerome Pederson | Director |
| Jeffery Sheldon | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1120 Nasa Parkway, Suite 600
Houston, TX, 77058
Houston, TX, 77058